Decreased expression of centrosomal protein 350 is associated with poor prognosis in hepatocellular carcinoma.

Wang, Y F; Ju, L L; Luo, X; Zhang, H; Bian, Z L

Wang, Y F; Ju, L L; Luo, X; Zhang, H; Bian, Z L.

Afiliação

Wang YF; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Ju LL; Nantong Institute of Liver Disease, Nantong Third People's Hospital Affiliated to Nantong University, Nantong, Jiangsu, China.
Luo X; Nantong Institute of Liver Disease, Nantong Third People's Hospital Affiliated to Nantong University, Nantong, Jiangsu, China.
Zhang H; Intensive Care Unit, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong, Jiangsu, China.
Bian ZL; Nantong Institute of Liver Disease, Nantong Third People's Hospital Affiliated to Nantong University, Nantong, Jiangsu, China.

J Biol Regul Homeost Agents ; 34(3): 1141-1146, 2020.

Article em En | MEDLINE | ID: mdl-32638577

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Carcinoma Hepatocelular/genética; Humanos; Neoplasias Hepáticas/genética

Palavras-chave

biomarker; centrosomal protein 350; hepatocellular carcinoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google